Cargando…

Epigallocatechin-3-gallate inhibits inflammation and epithelial-mesenchymal transition through the PI3K/AKT pathway via upregulation of PTEN in asthma

Asthma is a chronic disease associated with hyper-responsiveness, obstruction and remodeling of the airways. Epithelial-mesenchymal transition (EMT) has an important role in these alterations and may account for the accumulation of subepithelial mesenchymal cells, thus contributing to airway hyperre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Nan, Zhang, Han, Cai, Xuxu, Shang, Yunxiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752157/ https://www.ncbi.nlm.nih.gov/pubmed/29207033 http://dx.doi.org/10.3892/ijmm.2017.3292

Ejemplares similares

PTEN/AKT/mTOR signaling mediates anticancer effects of epigallocatechin-3-gallate in ovarian cancer
por: Qin, Jianli, et al.
Publicado: (2020)

Epigallocatechin gallate improves airway inflammation through TGF-β1 signaling pathway in asthmatic mice
por: Shan, Lishen, et al.
Publicado: (2018)

Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition
por: Kim, Sejin, et al.
Publicado: (2023)

Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
por: Yu, Hao-Han, et al.
Publicado: (2017)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

Epigallocatechin-3-gallate and cancer: focus on the role of microRNAs
por: Wang, Chunguang, et al.
Publicado: (2023)

Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis
por: Arffa, M. L., et al.
Publicado: (2016)

Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells
por: Hazgui, Salma, et al.
Publicado: (2008)

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer
por: Wang, Liu-Xiang, et al.
Publicado: (2019)

Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer
por: Zhang, Lingyun, et al.
Publicado: (2019)

Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate
por: Min, Kyoung-jin, et al.
Publicado: (2014)

Effects of Epigallocatechin-3-Gallate on Autophagic Lipolysis in Adipocytes
por: Kim, Sang-Nam, et al.
Publicado: (2017)

Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant
por: Cheong, Yucheol, et al.
Publicado: (2021)

Epigallocatechin-3-Gallate Reduces Neuronal Apoptosis in Rats after Middle Cerebral Artery Occlusion Injury via PI3K/AKT/eNOS Signaling Pathway
por: Nan, Wang, et al.
Publicado: (2018)

Epigallocatechin Gallate Relieved PM2.5-Induced Lung Fibrosis by Inhibiting Oxidative Damage and Epithelial-Mesenchymal Transition through AKT/mTOR Pathway
por: Zhongyin, Zhou, et al.
Publicado: (2022)

Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial–Mesenchymal Transition: Enhanced Efficacy When Combined with Gemcitabine
por: Wei, Ran, et al.
Publicado: (2019)

Epigallocatechin-3-gallate suppresses differentiation of adipocytes via regulating the phosphorylation of FOXO1 mediated by PI3K-AKT signaling in 3T3-L1 cells
por: Lu, Yi, et al.
Publicado: (2017)

Antioxidant and Cytoprotective Effects of (−)-Epigallocatechin-3-(3″-O-methyl) Gallate
por: Kim, Eunji, et al.
Publicado: (2019)

Structural Remodeling Mechanism of the Toxic Amyloid Fibrillary Mediated by Epigallocatechin-3-gallate
por: Zhang, Nan, et al.
Publicado: (2022)

(−)-Epigallocatechin-3-gallate induces secretion of anorexigenic gut hormones
por: Song, Won-Young, et al.
Publicado: (2015)

Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2016)

Effects of epigallocatechin-3-gallate on bovine oocytes matured in vitro
por: Huang, Ziqiang, et al.
Publicado: (2018)

Dietary Copper Reduces the Hepatotoxicity of (−)-Epigallocatechin-3-Gallate in Mice
por: Kaleri, Najeeb Ahmed, et al.
Publicado: (2017)

Epigallocatechin-3-Gallate Reduces Fat Accumulation in Caenorhabditis elegans
por: Liu, Jinning, et al.
Publicado: (2018)

Epigallocatechin-3-gallate counters cisplatin toxicity of rat testes
por: Fouad, Amr A., et al.
Publicado: (2017)

Green Tea Extracts Epigallocatechin-3-gallate for Different Treatments
por: Chu, Chenyu, et al.
Publicado: (2017)

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
por: Tang, L., et al.
Publicado: (2017)

Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1
por: Li, Xiaoguang, et al.
Publicado: (2017)

In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate
por: Wang, Wang, et al.
Publicado: (2019)

Effects of artificial honey and epigallocatechin-3-gallate on streptococcus pyogenes
por: Jiang, Xiaoge, et al.
Publicado: (2022)

Epigallocatechin Gallate Protects against MNNG-Induced Precancerous Lesions of Gastric Carcinoma in Rats via PI3K/Akt/mTOR Pathway
por: Zhu, Feiye, et al.
Publicado: (2021)

Epigallocatechin gallate & curcumin prevent transforming growth factor beta 1-induced epithelial to mesenchymal transition in ARPE-19 cells
por: Shanmuganathan, Sivasankar, et al.
Publicado: (2017)

(−)-Epigallocatechin-3-Gallate (EGCG) Enhances Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells
por: Lin, Sung-Yen, et al.
Publicado: (2018)

Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells
por: Kanlaya, Rattiyaporn, et al.
Publicado: (2016)

[Corrigendum] Epigallocatechin‑3‑gallate inhibits nicotine‑induced migration and invasion by the suppression of angiogenesis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells
por: Shi, Jingli, et al.
Publicado: (2023)

Promotor Hypomethylation Mediated Upregulation of miR-23b-3p Targets PTEN to Promote Bronchial Epithelial-Mesenchymal Transition in Chronic Asthma
por: Guo, Yimin, et al.
Publicado: (2022)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

Methylated (−)-epigallocatechin 3-O-gallate potentiates the effect of split vaccine accompanied with upregulation of Toll-like receptor 5
por: Kumazoe, Motofumi, et al.
Publicado: (2021)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_413la3pttls9oenl9d8hkbn6oe